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Calreticulin is a Ca2+-binding chaperone protein, which residesmainly in the endoplasmic
reticulum but also found in other cellular compartments including the plasma membrane.
In addition to Ca2+, calreticulin binds and regulates almost all proteins and most of
the mRNAs deciding their intracellular fate. The potential functions of calreticulin are
so numerous that identification of all of them is becoming a nightmare. Still the recent
discovery that patients affected by the Philadelphia-negative myeloproliferative disorders
essential thrombocytemia or primary myelofibrosis not harboring JAK2 mutations carry
instead calreticulin mutations disrupting its C-terminal domain has highlighted the
clinical need to gain a deeper understanding of the biological activity of this protein.
However, by contrast with other proteins, such as enzymes or transcription factors, the
biological functions of which are strictly defined by a stable spatial structure imprinted
by their amino acid sequence, calreticulin contains intrinsically disordered regions, the
structure of which represents a highly dynamic conformational ensemble characterized
by constant changes between several metastable conformations in response to a variety
of environmental cues. This article will illustrate the Theory of calreticulin as an intrinsically
disordered protein and discuss the Hypothesis that the dynamic conformational changes
to which calreticulin may be subjected by environmental cues, by promoting or restricting
the exposure of its active sites, may affect its function under normal and pathological
conditions.
Keywords: calreticulin, glucocorticoid receptor, erythropoietin receptor, stress erythropoiesis, myeloproliferative
disorders, intrinsically disordered proteins
INTRODUCTION
Calreticulin (CALR) is a Ca2+-binding protein expressed by all the cells and present in all their
compartments, which, as implied by its name, has the major function to bind, buffer, and control
intracellular Ca2+ levels (Wang et al., 2012). For long time, the functions of CALR were studied
by a restricted group of scientists interested in defining the role of Ca2+ signaling in the control of
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the cellular response to stress. These studies, however, quickly
identified that in the endoplasmic reticulum (ER), CALR binds
not only Ca2+, but also interacts with many ER proteins,
transiently associates with numerous different newly synthesized
glycoproteins as they enter the secretory pathway (Peterson
et al., 1995; Helenius et al., 1997; High et al., 2000), and even
interact with somemRNAs, thereby deciding their fate (Michalak
et al., 2009). Among established binding partners of CALR
are the E3 ubiquitin-protein ligase TRIM21 (tripartite motif-
containing protein 21, also known as 52 kDa ribonucleoprotein
autoantigen Ro/SS-A; Cheng et al., 1996), the glucocorticoid
receptor (GR, also known as the nuclear receptor subfamily
3 group C member 1, NR3C1; Holaska et al., 2001), PPIB
(peptidyl-prolyl cis-trans isomerase B, also known as cyclophilin
B; Kozlov et al., 2010a), GABARAP (Gamma-aminobutyric acid
receptor-associated protein; Thielmann et al., 2009), PDIA3
(protein disulfide-isomerase A3, also known as endoplasmic
reticulum resident protein 57, ERp57; Panaretakis et al., 2008),
PDIA5 (protein disulfide-isomerase A5; Vinaik et al., 2013), and
SPACA9 (sperm acrosome-associated protein 9, also known as
C9orf9, or Acrosome and sperm tail protein; Bhattacharya et al.,
2013). Furthermore, CALR serves as a component of the EIF2
(eukaryotic initiation factor 2) complex which also contains
the CUG triplet repeat RNA-binding protein 1 (CUGBP1,
also known as CUGBP Elav-like family member 1, CELF1),
Calreticulin-3 (CALR3), eukaryotic translation initiation factor
2 subunits 1 and 2 (EIF2S1 and EIF2S2), heat shock protein 90
kDa beta member 1 (HSP90B1, also known as endoplasmin),
and heat shock 70 kDa protein 5 (HSPA5, also known as 78 kDa
glucose-regulated protein, GRP-78; Timchenko et al., 2006). The
emerged functions of CALR are so numerous that it is impossible
to describe all of them.
Great general interest for studying the full array of CALR
functions has been recently raised by two clinical observations:
namely, CALR was shown to be expressed on the cell membrane
at levels which are altered in a variety of cancers (Chao
et al., 2010; Wemeau et al., 2010), and indel or deletion
mutations in exon 9 of CALR are associated with the majority
of Philadelphia-negative myeloproliferative neoplasms which do
not harbor mutations in JAK2 (Klampfl et al., 2013; Nangalia
et al., 2013; Nunes et al., 2015). These findings have inspired
numerous studies on the normal and pathological function of
CALR that up to now have used the well-established array
of experimental approaches which have been instrumental to
characterize the biological functions of many other proteins.
However, by contrast with many of the commonly studied
proteins which are characterized by well-defined 3D-structures,
CALR is an intrinsically disordered protein or, more correctly,
a hybrid protein, containing ordered domains and disordered
regions, and does not have a unique 3D structure for significant
part of its sequence (Shivarov et al., 2014;Migliaccio andUversky,
2017). This fact poses novel challenges to biochemical and
molecular biology investigators. This Hypothesis and Theory
article will summarize CALR features that are “unique” due to
its intrinsically disordered nature and hypothesize how these
features affect our understanding of the biological and clinical
implications of the protein.
STRUCTURAL FEATURES OF NORMAL
HUMAN CALR
Primary and Secondary Structure
CALR is synthesized in the form of a precursor protein
containing an N-terminally located signal peptide (residues
1–17). To avoid confusion, CALR residues will be numbered
according to the amino acid (AA) sequence of the pre-protein
(Figure 1). Mature CALR has a predicted molecular weight of
46 kDa and can be divided into three domains: the N-terminal
(N-CALR, residues 18–197 in the UniProt ID: P27797), the
proline-rich (P-domain, residues 198–308), and the C-terminal
(C-CALR, residues 309–417) domains (Michalak et al., 1999;
Figure 1).
N-CALR is encoded by a highly conserved AA sequence that
is folded in a stable globular structure with eight antiparallel β-
strands (Michalak et al., 1999, 2009). N-CALR is an important
functional domain that includes polypeptide- and carbohydrate-
binding sites (Leach et al., 2002; Kapoor et al., 2004), a Zn2+-
binding site (Baksh et al., 1995), and a disulfide-linkage site
(Andrin et al., 2000).
P-CALR consists of an extended region stabilized by
three antiparallel β-strands (Ellgaard et al., 2001a), which
includes three consecutive repeats of two AA sequences
(PXXIXDPDAXKPEDWDE and GXWXPPXIXNPXYX,
respectively) that have been associated with the lectin-like
chaperone function of the protein (Michalak et al., 2009).
P-CALR binds Ca2+ with high affinity (Kd = 1µM), but low
capacity (1 Ca2+ per protein; Michalak et al., 1999, 2009).
C-CALR has a highly acidic AA composition and is
responsible for binding over 50% of the Ca2+ present in the
ER lumen (Nakamura et al., 2001) with high capacity and low
affinity (up to ∼20 ions of Ca2+ per 1 molecule of CALR,
Kd ∼2mM; Michalak et al., 2009). C-CALR exerts the Ca2+-
buffering functions of the protein (Baksh and Michalak, 1991)
and contains the KDEL (Lys-Asp-Glu-Leu) signal required for
protein translocation across the ER membranes (Michalak et al.,
2009).
CALR does not contain neither a transmembrane domain nor
a GPI-anchor attachment site and instead is anchored to the
membranes via specific adaptors, such as CD59 in neutrophils
(Ghiran et al., 2003), or the receptors for thrombopoietin,
erythropoietin or granulocyte colony stimulating factor (G-CSF)
in other hematopoietic cells (Araki et al., 2016; Chachoua et al.,
2016).
Tertiary Structure and Intrinsic Disorder
The beginning of the twenty-first century saw a paradigm
shift in our understanding of the 3D-structure of a protein
(Dunker et al., 2001; Uversky and Dunker, 2012). It became
clear that under physiological conditions the primary sequence
of many proteins is not sufficient to determine a unique
3D-structure. As a result, such proteins often contain regions
of structural instability (defined as intrinsically disordered
regions) or do not have ordered structure as a whole (are
intrinsically disordered). Such intrinsically disordered nature
defines the highly flexible character of such proteins that exist
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FIGURE 1 | Linear diagram of human calreticulin indicating its amino-terminal (N-CALR), globular (P-CALR), and carboxy-terminal (C-CALR) domains and the location
of the sequences predicted by computer modeling to determine an intrinsically disordered structure (indicated by the straight lines). (A) Normal human CALR and
factors which may potentially affect its tertiary structure. In addition to the presence of sequences which determine the intrinsically disordered structure (straight lines),
the tertiary structure of CALR is affected by the levels of Ca2+ bound to C-CALR and by binding of other proteins to putative MoRFs sequences (circles and lines).
The black circle indicates MoRF3 which has a known putative binding protein. The dashed line indicate the region between AA 260–330 AA predicted by computer
modeling to have a stable conformation (i.e., lacking intrinsically disordered regions, binding sites for Ca2+ or MoRFs). The blue boxes indicate the location of the
sequences used to raise the commercially available antibodies against human N-CALR (#12238, Cell Signaling, Boston, MA) and C-CALR (sc-6467, Santa Cruz
Biotechnology, Santa Cruz, CA). Asterisks indicate putative JAK2-dependent phosphorylation sites. (B) Diagram of the structure of representative Type 1 (deletions)
and Type 2 (insertions) CALR mutations found in Philadelphia-negative myeloproliferative disorders. The mutations found in these maladies are all localized in exon 9
encoding the terminal C-region of the protein and encode a truncated (Type 1, top diagram) or elongated (Type 2, bottom diagram) form of C-CALR. In both cases,
the mutated C-CALR loses the KDEL motive necessary for translocation in the ER. The mutations induce also loss of sites in the C domain responsible for Ca2+
binding, of three of the putative JAK2-dependent phosphorylation sites and two MoRFs sites (see Table 1 for further details). The mutant proteins may also lose the
sequence used to generate the anti-C-CALR antibody commercially available. In this figure, as in rest of the manuscript CALR AA are numbered starting from the first
AA of the signal sequence.
as dynamic conformational ensembles, which allows them to
continuously shift among several possible conformations in
response to environmental cues. In other words, the structure of
the protein is in a dynamic equilibrium among multiple discrete
conformational states. Several computer programs exist which
are dedicated to the discovery of the intrinsically disordered
regions of a protein and to the functional characterization
of such regions (e.g., finding of the disorder-based binding
sites).
The intrinsic disorder predisposition of CALR was identified
by two independent multiparametric computational analyses
(Shivarov et al., 2014; Migliaccio and Uversky, 2017), which
utilized, respectively, either PONDR-FIT (Xue et al., 2010) and
RONN (Yang et al., 2005) disorder predictors (Shivarov et al.,
2014) or four different algorithms from the PONDR family (Li
et al., 1999; Romero et al., 2001; Obradovic et al., 2005; Peng
et al., 2005, 2006; Xue et al., 2010) and the IUPred web server
(Dosztányi et al., 2005; Migliaccio and Uversky, 2017). These
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analyses revealed that the N-domain was expected to be mostly
ordered, whereas the P-domain and the C-terminal tail of C-
domain were highly disordered. Figure 2A represents results
of the analogous computational analysis, where the per-residue
intrinsic disorder propensity of human CALR is evaluated by
PONDR-FIT (Xue et al., 2010), PONDR R© VLXT (Dunker et al.,
2001), PONDR R© VSL2 (Obradovic et al., 2005), and PONDR R©
VL3 (Obradovic et al., 2003), as well as by the IUPred web
server with its two versions for predicting long and short
disordered regions (Dosztányi et al., 2005). These computational
tools were selected because of their specific features. PONDR R©
VSL2 is one of the most accurate stand-alone disorder predictors
(Obradovic et al., 2005), PONDR R© VL3 possesses a high
accuracy for finding long disordered regions (Obradovic et al.,
2003), PONDR R© VLXT is not the most accurate predictor, but
has a high sensitivity to local sequence peculiarities which are
often associated with disorder-based interaction sites (Dunker
et al., 2001), PONDR-FIT is a metapredictor that is moderately
more accurate than each of the component predictors and that
is one of the most accurate disorder predictors (Xue et al., 2010),
whereas IUPred utilizes the pair-wise energy estimation approach
for finding intrinsically disordered residues/regions and can
be used for finding both short and long disordered regions
(Dosztányi et al., 2005).We also evaluated the consensus disorder
propensity of human CALR by averaging disorder profiles of
individual predictors. The use of consensus for evaluation of
intrinsic disorder was motivated by empirical observations that
the predictive performance can be increased by this approach
compared to the use of a single predictor (Peng andKurgan, 2012;
Fan and Kurgan, 2014; Walsh et al., 2015). Figure 2A clearly
shows that human CALR is expected to have two long disordered
regions, residues 196–280 and 350–417 corresponding to the
large portion of P-CALR and the acidic C-tail, respectively.
The presence of potential disorder-based protein binding sites
in human CALR was evaluated by the ANCHOR algorithm
(Dosztányi et al., 2009). This algorithm utilizes the pair-
wise energy estimation approach originally used by IUPred
(Dosztányi et al., 2005). This approach is based on the hypothesis
that long disordered regions might include localized potential
binding sites, which are not capable of folding on their own
due to not being able to form enough favorable intrachain
interactions, but can obtain the energy to stabilize via interaction
with a globular protein partner (Dosztányi et al., 2009). This
ANCHOR analysis revealed that the intrinsically disordered
regions of CALR contain five putative disorder-based protein
binding sites (molecular recognition features, MoRFs) that can
fold as a result of the interaction with specific partners (residues
170–176, 198–204, 259–269, 304–352, and 409–417; Figure 2A
and Table 1), suggesting that these regions can be used for
promiscuous protein-protein interactions. The five MoRFs are:
a) MoRF1: a β-strand in the core structure of CRT, on the outer
side interacting with the C-terminal α-helix (shown in red in
Figure 3A).
b) MoRF2: The initial part of the P-arm that functions as a switch
between the closed and open conformation in parisite CALRs
(Moreau et al., 2016; shown in green in Figure 3A).
FIGURE 2 | Intrinsic disorder propensity of wild-type human CALR (A) and of
the construct of human CALR used in the crystallization study. (A) Evaluating
intrinsic disorder propensity of human CALR (UniProt ID: P27797) by series of
per-residue disorder predictors. Disorder profiles generated by PONDR®
VLXT, PONDR FIT, PONDR® VL3, PONDR® VSL2, IUPred_short, and
IUPred_long are shown by black, red, green, yellow, blue, and pink lines,
respectively. Dashed dark red shows the mean disorder propensity calculated
by averaging disorder profiles of individual predictors. Light pink shadow
around the PONDR® FIT shows error distribution. In these analyses, the
predicted intrinsic disorder scores above 0.5 are considered to correspond to
the disordered residues/regions. Positions of the MoRF regions are shown as
gray shaded areas. Modified from Migliaccio and Uversky (2017). (B) Intrinsic
disorder propensity of the crystallized construct of human CALR described in
Figure 3A by series of per-residue disorder predictors. The amino acid
sequence of this construct includes the N-domain (residues 18–204) and the
N-terminal half of the C-domain (residues 303–368) connected by a GSG
tripeptide. Disorder profiles generated by the same program described in (A)
[see legend of (A) for further details]. See Migliaccio and Uversky (2017).
c) MoRF3: part of the down-stream of the P-arm (shown in red
in Figure 3B).
d) MoRF4: The inserted β-strands of the C-terminal region and
the first part of the α-helix (shown in ice-blue in Figure 3A).
e) MoRF5: The tip of the C-terminal region (containing the
KDEL sequence; not present in the crystallized construct
presented in Figure 3).
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TABLE 1 | Effects of the CALR mutations identified so far in patients with myeloproliferative neoplasm on the intrinsic disorder-based interactivity of the protein.
Mutation MoRF1 MoRF2 MoRF3 MoRF4 MoRF4′ MoRF5 MoRF5′
Wild type 170–176 198–204 259–269 304–352 409–417
TYPE 1
p.E378Cfs*36 170–176 198–204 259–269 304–334 405–415
p.K374Nfs*47 170–176 198–204 259–269 304–335 410–422
p.D373Rfs*48 170–176 198–204 259–269 304–335 409–422
p.D373Gfs*53 170–176 198–204 259–269 304–335 384–392 413–427
p.D373Vfs*57 170–176 198–204 259–269 304–334 416–428
pD373Afs*51 170–176 198–204 259–269 304–334 382–388 411–425
p.L367Tfs*46 170–176 198–204 259–269 304–334 401–414
p.Q368Rfs*47 170–176 198–204 259–269 305–333 401–414
p.K360Wfs*49 170–176 198–204 259–269 305–333 398–410
p.E370Vfs*43 170–176 198–204 259–269 304–334 399–411
p.E370Qfs*48 170–176 198–204 259–269 304–334 406–419
p.L367Qfs*48 170–176 198–204 259–269 304–334 403–416
p.L367Rfs*44 170–176 198–204 259–269 305–334 398–411
p.K368Rfs*51 170–176 198–204 259–269 304–334 406–420
p.L367Rfs*52 170–176 198–204 259–269 304–334 378–384 406–420
p.R366Kfs*53 170–176 198–204 259–269 304–334 378–385 406–420
p.E371Rfs*49 170–176 198–204 259–269 304–334 407–421
p.K368Mfs*43 170–176 198–204 259–269 305–333 400–412
p.E370Rfs*37 170–176 198–204 259–269 304–334 394–405
p.E373Rfs*47 170–176 198–204 259–269 304–334 408–421
p.K374Rfs*53 170–176 198–204 259–269 304–335 385–393 414–428
p.E371Rfs*49 170–176 198–204 259–269 304–334 406–419
TYPE 2
p.K385Nfs*47 170–176 198–204 259–269 304–338 388–394 418–430
p.K385Lfs*47 170–176 198–204 259–269 304–337 385–393 418–430
COMPLEX
p.K376Lfs*55 170–176 198–204 259–269 304–334 389–397 419–432
p.K385Sfs*47 170–176 198–204 259–269 304–338 388–396 420–433
p.E381Dfs*48 170–176 198–204 259–269 304–337 386–393 417–430
Expected effects of indel mutations on the interactivity of CALR were evaluated by the ANCHOR algorithm (Dosztányi et al., 2009; Mészáros et al., 2009). To this end, the AA sequence
of each mutant (column 1) was analyzed by ANCHOR and the corresponding outputs (positions of MoRFs) were tabulated. Some of the indel Type 1 mutations and all the deletion Type
2 mutations induce formations of novel MORFs indicated in the column MoRF4′ and MoRF5′.
Based on the crystallografic analysis of a construct containing
the N-domain (residues 18–204) and the N-terminal half of
the C-domain (residues 299–368) of human CALR connected
by a GSG tripeptide but lacking the entire P-domain and
C-terminal tail of the C-domain (see below), MoRF1 andMoRF4
are integral parts of the core region of CALR and unlikely to
change conformation unless the entire core region is rearranged.
Although, the core retains its overall structure both in the
presence and absence of Ca2+ (Boelt et al., 2016), this possibility
is theoretically possible and deserves to be further investigated.
Since MoRF2 is located in a region that serves as a switch
between the closed and open conformation [at least in the
CALR from two distinct parasites, Trypanosoma cruzi (TcCALR)
and Entamoeba histolytica (EhCALR; Moreau et al., 2016)], this
molecular recognition feature clearly deserves further analysis.
However, both MoRF3 and MoRF5 are likely to be disordered
in their unbound forms, as great mobility of the regions they
are located within has been generally agreed upon and shown in
many cases. The fact that MoRF3 and MoRF5 are those mostly
affected by SNPs associated with cancer (see below) strongly
suggests that they play relevant biological functions.
It is possible that the intrinsically disordered nature of CALR
may determine which of these sites are exposed at any given
moment, and therefore which protein can be engaged in CALR
binding. On the other hand, binding of the protein partners
to these regions may affect the 3D-structure of CALR, thereby
ensuring a two-way regulation between the two partners.
Despite the general knowledge of high binding promiscuity
of CALR (as aforementioned, this protein was shown to interact
with many proteins and numerous partially folded substrates
present in ER; Michalak et al., 2009), the only CALR partner with
a known binding site identified so far is peptidyl-prolyl cis-trans
Frontiers in Cell and Developmental Biology | www.frontiersin.org 5 November 2017 | Volume 5 | Article 96
Varricchio et al. Intrinsic Disorder in CALR Protein
FIGURE 3 | Structural characterization of human and rat CALR. (A) X-ray
crystal structure of the N-domain human of CALR (residues 18–204) and the
N-terminal half of the C-domain (residues 303–368) connected by a GSG
tripeptide (PDB ID: 3POW; Chouquet et al., 2011). The expected localization
of MoRF1 (residues 170–176, in red), MoRF2 (residues 198–204, green), and
MoRF4 (residues 304–352, ice-blue) in the crystal structure of the human
protein is indicated. Note that in this construct, the P-domain is removed and
replaced by the GSG tripeptide. With the exception to MoRFs that have their
own color coding (see above), CALR structure is colored according to the
secondary structure content, with β-strands, α-helices, 310 helices, β-turns,
and irregular structure shown by yellow, purple, blue, cyan, and white colors,
respectively. (B) Solution NMR structure of the P-domain of the rat CALR
(residues 206–305 in UniProt ID: P18418) (PDB ID: 1HHN; Ellgaard et al.,
2001b). NMR analysis generates an ensemble of structures, all of which are
consistent with the observed experimental restraints. Shown here is a
conformational ensemble representing structure of the P-domain, which is one
of the regions removed from the construct used in the crystallization studies of
the human protein (see Figure 3A). This conformational ensemble contains an
overlay of 20 molecular models, each shown by its own color. A highly dynamic
nature of the conformational ensemble describing structure of P-CALR is
evidenced by the “fuzzy” appearance of the conformational ensemble
describing its solution structure. (C) Solution NMR structure of one of the
members of the P-domain dynamic conformational ensemble (model 1 in PDB
ID: 1HHN; Ellgaard et al., 2001b). Position of MoRF3 (residues 259–269) is
indicated in red. With the exption to this MoRF, structure of P-CALR is colored
according to the secondary structure content, with β-strands, β-turns, and
irregular structure shown by yellow, cyan, and white colors, respectively.
isomerase B, which binds residues 237–270 (Kozlov et al., 2010a),
a region overlapping with MoRF3 (residues 259–269).
An intrinsically disordered structure appears to be a common
feature of proteins exerting chaperone functions. In fact, in
addition to CALR, several studies have indicated that numerous
protein and RNA chaperones are either disordered or contain
intrinsically disordered regions needed for their functionality
(Tompa and Csermely, 2004; Tompa and Kovacs, 2010; Kovacs
and Tompa, 2012). These proteins include late embryogenesis
abundant (LEA) and other stress-related plant proteins (Kovacs
et al., 2008a,b; Cuevas-Velazquez et al., 2017), human chaperones
engaged in neurodegenerative diseases (Uversky, 2011), histone
chaperones (Liu et al., 2017; Warren and Shechter, 2017), a
redox-regulated chaperone Hsp33 (Rimon et al., 2017), small
heat shock proteins (Sudnitsyna et al., 2012), and the heat shock
transcription factors (Westerheide et al., 2012).
The intrinsically disordered nature of long regions in CALR
has challenged crystallization of the full-length human protein
(Chouquet et al., 2011). As a result, X-ray crystallographic
structure is currently available only for a construct of human
CALR containing the N-domain (residues 18–204) and the N-
terminal half of the C-domain (residues 299–368) connected
by a GSG tripeptide but lacking the entire P-domain and C-
terminal tail of the C-domain (PDB ID: 3POW; Chouquet et al.,
2011). Similarly engineered constructs were also used to obtain
crystal structures of mouse CALR (PDB ID: 3O0W; Kozlov et al.,
2010b), as well as CALR from the parasite T. cruzi (PDB ID:
5HCF; Moreau et al., 2016). In these studies, mouse construct
contained the N-domain (residues 18–206) connected by a short
linker to the N-terminal half of the C-domain (residues 301–
368), whereas the parasite construct included the N-domain
(residues 22–207) and a shorter fragment of the N-terminal
half of the C-domain (residues 338–362) also connected by a
short linker. Since the resulting structures of the recombinant
human, mouse, and Trypanosoma proteins were rather similar,
only the crystal structure of the human construct is discussed
below as an example. Figure 3A shows that the structure of
human construct is characterized by a jelly-roll fold formed by
one convex and one concave anti-parallel β-sheets (Chouquet
et al., 2011). The part of the C-domain, which is integrated
into the globular domain, provides two central strands to the
β-sandwich structure and adds a long kinked C-terminal α-
helix (Chouquet et al., 2011). These observations suggest that
the overall CALR structure can be viewed as a globular body
comprised of the N-domain and the N-terminal half of the C-
domain (structure of which can be resolved crystallographically)
with two flexible and functionally different arms corresponding
to the P-domain (residues 198–308) and C-tail (residues 370–417;
Michalak et al., 2009; Wijeyesakere et al., 2011). In agreement
with this model, crystal structure of the lumenal domain of
dog calnexin (residues 45–468 of the UniProt ID: P24643) that
includes an entire intact P-arm (residues 277–410) showed that
this protein (which is a type-I integral membrane protein serving
as another lectin-like chaperone in the endoplasmic reticulum)
contains a compact globular domain (residues 61–262, 415–458)
with a structure characteristic of legume lectins; i.e., a β-sandwich
of two antiparallel β-sheets, and a 145-residue long arm (residues
270–414) protruding 140 Å away from the globular domain (PDB
ID: 1JHN; Schrag et al., 2001).
Curiously, application of the ANCHOR algorithm to the
sequence of a human CALR used in the crystallization study
revealed that all MoRFs predicted in the original natural protein
were eliminated due to the removal of P-domain and C-terminal
tail of the C-domain. This is rather unexpected consequence,
since the analysis of the full-length CALR predicts that only
MoRF3 (residues 259–269) and MoRF5 (residues 409–417) are
removed from the chimeric protein used for crystallization (the
CALR regions containing these MoRFs are not included in the
crystallizable construct) while MoRF1 (residues 170–176) and
MoRF2 (residues 198–204), which are located in the N-terminal
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domain, (residues 18–204), and MoRF4 (residues 304–352),
which is contained in the N-terminal half of the C-domain
(residues 299–368) should be retained. These considerations are
exemplified by a comparison of Figures 2A,B which indicates
that not only the overall disorder predisposition of CALR, but
also its predicted disorder-based functionality are dramatically
affected by removal of the P-domain and of the C-terminal
tail of the C-domain. Although, MoRFs were not predicted by
computer program in the sequence of the crystallized CALR
construct, we marked the expected positions of MoRF1 (residues
170–176, red), MoRF2 (residues 198–204, green), and MoRF4
(residues 304–352, ice-blue) in the crystal structure of human
protein presented in Figure 3A. Of these three MoRFs, only
MoRF2, which is located in a loop region, is accessible to
solvents, whereas MoRF1 serves as a β-strand located on the
outer side of the core structure of CALR and interacts with the
C-terminal α-helix and MoRF4 exists in the form of the inserted
β-strands of the C-terminal region and the first part of the α-helix
(Figure 3A). It is the observation that MoRF1 and MoRF4 are
integral parts of the core region of the crystallized human CALR
that leads to the conclusion that for them to undergo changes in
conformation requires rearrangement of the entire core region.
However, it is important to remember that this crystal structure
was obtained with a construct which lacked the most flexible
regions of the protein and contained only 3 residues instead
than the almost 100 residues of the highly dynamic region of
the P-domain. Since these sequence alterations may dramatically
affect the structure and dynamics of CALR, the resolved X-
crystallographic structure of this construct may not predict that
of the functional protein.
Although, no detailed structural information is currently
available for the P-domain of human CALR, the NMR solution
structure was solved for the analogous region of the rat protein
(residues residues 206–305 in UniProt ID: P18418) (PDB ID:
1HHN; Ellgaard et al., 2001b). Overall human and rat proteins
have high level of sequence identity (97.5%), and also rat
CALR is predicted to have five MoRFs located at positions
almost identical to that of the corresponding MoRFs in the
human protein (residues 171–176, 198–204, 259–269, 303–350,
and 408–416 of the mature form of rat CALR). Since the
AA sequences of the P-domains of human and rat CALR
are almost identical, the structure determined for the rat P-
domain may elucidate structural peculiarities of the human
P-domain. Figure 3B shows that in rat CALR this region is
characterized by an extremely high structural flexibility, which
is evidenced by the “fuzzy” appearance of it structural ensemble
containing 20 individual chains. To present a clearer view,
Figure 3C represents the structure of a representative members
of this dynamic conformational to illustrate that the P-domain
is characterized by an unusual extended hairpin fold with
high conformational flexibility (Ellgaard et al., 2001b). It was
indicated that two very short β-strands, residues 224–226 and
248–250, constitute an anti-parallel β-sheet that closes the central
loop (residues 227–247) of this domain that also contains two
additional two-stranded antiparallel β-sheets comprising pairs
of short β-strands, residues 207–209 and 262–264, and 190–
192 and 276–278 (Ellgaard et al., 2001b). Figure 3C shows that
MoRF3 (residues 259–269) includes one of the aforementioned
short β-strands (residues 262–264). Recently, small-angle X-ray
scattering (SAXS) analysis revealed that the intact human CALR
is characterized by a highly asymmetric structure containing
extended globular structure formed by the N- and C-terminal
domains and a highly flexible P-domain (P-loop) protruding
from the globular part, and with the acidic C-terminal tail
occupying a volume opposite the P-loop relative to the core
region (Nørgaard Toft et al., 2008). These SAXS results provided
strong support to the notion that CALR is characterized by
a highly dynamic structure containing globular core decorated
with long flexible regions.
Subsequent biophysical studies added a novel twist to the
characterization of the intrinsically disordered nature of CALR
by indicating that the overall tertiary structure of this protein
can be described in terms of metastable equilibrium between
two conformational ensembles, which is sensitive to the Ca2+
concentration present in solution (Villamil Giraldo et al., 2010;
Wijeyesakere et al., 2011; Migliaccio and Uversky, 2017). Ca2+
binding was shown to reduce the overall solvent accessibility
of the hydrophobic core of the full-length CALR (measured
as changes in the fluorescence parameters of the hydrophobic
fluorescent probe ANS) and to increase its compaction. It also
affected urea-induced unfolding of the protein, providing further
support to the idea that Ca2+ shifts its conformational ensemble
toward more folded conformations. The same studies, however,
when conducted on isolated domains provided strikingly
different results. In fact, Ca2+ concentrations did not affect
neither the structure nor the conformation stability of the
isolated P-domain while had some but minimal effects on
that of the C-domain, indicating that the effects of Ca2+ on
the intrinsically disordered nature of CALR are manifested
only when the two domains are both present (Migliaccio
and Uversky, 2017). Of note, all these biophysical studies
were performed at physiologic Ca2+ concentrations (0.01–
100 nM in the endoplasm, 50–500µM in the ER) providing
indication that the described structural changes may also occur
in vivo (Villamil Giraldo et al., 2010; Wijeyesakere et al., 2011;
Migliaccio and Uversky, 2017). The concept of physiological
Ca2+ concentrations is rapidly evolving: intracellular Ca2+
concentrations in mammalian cells are in the 10–100 nM range
at steady state and increase by 10- to100-fold (0.1–1µM) upon
stimulation. Since these concentrations are much lower than that
present in human plasma [2mM], it is possible that one of the
functions of the structural changes of CALR is to prevent Ca2+
shocks when the cells are overstimulated. However, is spite of the
important role exerted by CALR in controlling Ca2+ homeostasis
in vivo, the levels of Ca2+ bound to this protein inside cells
exposed to different conditions are still poorly characterized.
The high sensitivity of the CALR structure to Ca2+
concentration has potential functional importance, since several
studies indicated that the chaperone activity of CALR is
Ca2+-dependent (Wiuff and Houen, 1996; Rizvi et al., 2004;
Conte et al., 2007). In agreement with these conclusions and
observations, a careful analysis of the effect of Ca2+ binding on
structural properties of the full-length mature CALR conducted
by Boelt et al. using chemical cross-linking, mass spectrometry,
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bioinformatics analysis, and modeling in Rosetta revealed that
the overall structure of this protein undergoes large Ca2+-
induced changes (Boelt et al., 2016). In fact, the acidic C-
terminal region of CALR was shown to move relative to the
core in the Ca2+-dependent manner, and the highly flexible P-
loop moved closer to the protein core and the acidic C-terminal
tail following the Ca2+ binding (Boelt et al., 2016). These Ca2+-
promoted structural changes causing relatively close interaction
of the P-loop with the acidic C-terminal region were suggested
to sterically occlude the lectin site/peptide binding site of CALR,
thereby providing the first structural hint on the molecular
mechanisms underlying the Ca2+-dependent regulation of CALR
functionality (Boelt et al., 2016). The importance of the Ca2+-
dependent interaction of P-CALR and acidic C-tail with the
globular core for regulation of the chaperone function of this
protein is further supported by the fact that the polypeptide
binding conformation of CALR can be induced by heat shock,
calcium depletion, or by deletion of the C-terminal acidic region
(Rizvi et al., 2004).
Detailed structural analysis of CALR is complicated not only
by the presence of long disordered regions, but also by the
tendency of this protein to dimerize and self-oligomerize, a
property that was shown to be important for the chaperone
activity of CALR, since self-oligomerization noticeably increased
CALR binding to peptides and denatured proteins (Jørgensen
et al., 2003; Rizvi et al., 2004; Boelt et al., 2016) and also promoted
its immunological activities (Huang et al., 2013; He et al., 2014).
Obviously, any experimental technique that is used for the
analysis of structural properties and conformational behavior of
wholly disordered proteins can by applied for the investigation of
isolated domains of CALR. Note that this “dissection” approach
was successfully used in several previous studies dedicated to
CALR that also discussed the intrinsically disordered nature of
CALR and the intrinsic disorder status and high flexibility of
the C- and P-domains of this protein (Bouvier and Stafford,
2000; Li et al., 2001; Nørgaard Toft et al., 2008; Yan et al., 2010;
Wijeyesakere et al., 2011).
Although, the highly dynamic nature of the structure of
intrinsically disordered proteins makes their structural analysis
challenging, suitable techniques are being rapidly developed in
numbers that are already approaching a few dozen (Uversky and
Dunker, 2012; Uversky, 2015). These techniques are represented
by a host of biophysical methods that provide information
on the overall compactness, conformational stability, shape,
residual secondary structure, transient long-range contacts,
regions of restricted, or enhanced mobility, etc., of such proteins
(Uversky and Dunker, 2012; Uversky, 2015). Because of their
highly heterogeneous nature and conformational dynamics at
multiple time-scales, the full spectrum of structural and dynamic
characteristics of disordered proteins cannot be gained by a
single tool and clearly requires multi-parametric approaches
(Uversky and Dunker, 2012; Uversky, 2015). The structural
characterization of the full-length CALR may also be tackled
with experimental approaches such as a combination of chemical
cross-linking with mass spectrometry (MS) and structure
modeling (Back et al., 2003; Sinz, 2003, 2006; Jin Lee, 2008;
Leitner et al., 2010; Peng et al., 2014; Sinz et al., 2015) which has
already provided important information about CALR (Nielsen
et al., 2007; Boelt et al., 2016). Other suitable techniques which
may be used in the future are represented by heteronuclear
multidimensional NMR, in-cell NMR, fluorescence resonance
energy transfer (FRET), the H/D exchange analysis, limited
proteolysis, a combination of SAXS with high-resolution
NMR, atomic force microscopy-based single molecule force
spectroscopy, high-speed atomic force microscopy, and single
molecule FRET.
Post-translational Modification
CALR is synthesized as a precursor protein which undergoes
proteolytic cleavage of its first 17 AA that are necessary to target
the protein to the lumen of the ER. Once this N-terminal region
is cleaved, CALR is accumulated in the ER thanks to the presence
of the C-terminal KDEL retentionmotif. Computational analyses
(http://ptmfunc.com/) predict that CALR may be subjected to
several post-translational modifications. In fact, these programs
have identified six putative ubiquitination sites (K48, K55, K143,
K153, K159, and K206) and nine putative acetylation sites (K48,
K62, K64, K153, K159, K206, K207, K209, and K238) in its
N-CALR and P-CALR domains. Computer analyses (http://
KinasePhos2.mbc.nctu.edu.tw/) also revealed the presence of
14 putative JAK2-dependent phosphorylation sites distributed
along the entire length of the protein (Figure 1A). All these
modifications have the potential to alter the 3D-structure and
function of the protein. However, whether CALR is subjected at
least to some level of post-translational modification has not been
established as yet.
Experimental Challenges Posed by the
Intrinsically Disordered Nature of CALR
Traditionally, protein biochemical studies involve size
fractionation by electrophoresis in polyacrylamide gels
containing urea and sodium dodecyl-sulfate (SDS-PAGE),
which denature and linearize the proteins allowing their further
identification with specific antibodies. SDS-PAGE has been
optimized in order to efficiently disrupt all non-covalent
interactions, to dissolve protein-based complexes, and to
linearize the molecules, making all their part equally accessible
to antibodies. However, intrinsically disordered proteins have
been shown to be resistant to SDS-PAGE denaturation. Several
of them may remain in a non-covalently bond state with other
proteins upon SDS treatment and to run as complexes on
SDS-PAGE (Tramentozzi et al., 2008; Shimada and Kitada,
2011; Das et al., 2012; Falson et al., 2015; Sadler et al., 2015).
Furthermore, hydrophilic residues of disordered proteins and
hybrid proteins containing ordered and disordered regions,
such as the Xenopus XPA (Xeroderma pigmentosum group
A) and the prostate-associated gene 4 protein, may bind SDS
poorly, which allows them to migrate noticeably slower than
the migration expected on the basis of their AA sequence
(Iakoucheva et al., 2001; Tompa, 2002; Receveur-Bréchot et al.,
2006; Zeng et al., 2011; Uversky and Dunker, 2012). As predicted
by the highly disordered proline-rich domain and highly acidic
C-tail of the protein and demonstrated more than 40 years
ago, CALR binds SDS poorly and, therefore, is resistant to
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SDS-induced linearization. In addition, the aforementioned
biophysical studies on the urea-induced unfolding of CALR and
its isolated domains suggest that also the sensitivity of CALR
to urea may be limited by the amount of Ca2+ bound to the
protein, possibly as a reflection of the concentration of this ion
in the cells being analyzed. The fact that CALR partially retain
its 3D-structure in SDS-PAGE explains why CALR migrates in
SDS-PAGE with an apparent molecular weight greater (55–60
KDa) than the theoretical 46 KDa expected on the basis of its AA
sequence (Michalak et al., 1992; Klampfl et al., 2013; Nangalia
et al., 2013; Falchi et al., 2017). Although, it is still unclear
whether CALR undergoes post-translational modifications, all
the aforementioned post-translational modifications have the
potential to affect SDS binding at least to some of its domains
allowing CALR to retain some globular structure.
As consequence of retention of tertiary structures, epitopes
of the protein, which were poorly exposed in vivo may remain
poorly exposed after SDS-PAGE separation, affecting their
accessibility by antibodies in Western blot analyses. Of note,
some of the currently available commercial antibodies were
raised against AA sequences in the N-CALR and C-CALR
domains whose structure is predicted by computational analyses
to be in a metastable equilibrium sensitive to environmental cues
(Figure 1). For this property, these antibodies may be exploited
for epitope mapping studies to identify how the conformation of
the protein changes in vivo in response to micro-environmental
cues as pioneered by the study of Falchi et al. (2017). The
resolution of in vivo epitope mapping studies is however still low
and need to be increased by using panels of antibodies against a
wider range of domains of intrinsically disordered and ordered,
as internal control, regions of CALR (Figure 1A).
An additional challenge is represented by the ability of
CALR to bind numerous proteins. In fact, the immunoglobulins
themselves represent such a contamination of samples obtained
by immunoprecipitation performed with CALR antibodies that
the accurate identification of the additional proteins pulled
down by them is almost impossible. Therefore, studies aimed
to the identification of the interactome of CALR may need the
development of reagents and immunoprecipitation conditions
specific for intrinsically disordered proteins.
The intrinsically disordered nature of CALR and the high
numbers of partners with which it may be associated also
challenge confocal microscopy studies. In fact, because of this
caveat, the levels of CALR detected inside a cell by confocal
microscopy do not necessary reflect CALR content but may
instead indicate the level of exposure of the epitope recognized
by the antibody. This is specifically true for antibodies raised
against regions of the protein involved in binding with their
partners. Therefore, confocal microscopy study should always
be performed with multiple antibodies and results confirmed by
biochemical studies with purified subcellular compartments.
Last but not least, the intrinsic disordered nature of CALR
may also challenge the application of recombinant technologies
which have provided a paradigm shift in our way to study
protein structure/function relationship. These studies usually
involve generation of recombinant genes encoding only part
of a protein often linked with a fluorescent tag that may be
also recognized by an antibody or a lectin. All these studies
are under the assumption that these genetic modifications
do not alter the structure and therefore the function of the
recombinant protein. These techniques are presently used by
many investigators also to study CALR functions. However, as
discussed earlier, numerous biophysical studies indicate that the
tertiary structure of the individual domains of CALR is strictly
dependent on their connections with the other domains. In
addition, the recombinant tags, such as the green-fluorescent
protein (GFP) used for in-vivo imaging or the variety of
small, medium and large tags used to study the interactome
of a protein [e.g., epitope tags, such as FLAG, six histidines
(His)6, c-Myc, hemaglutinin (HA), glutathione-S-transferase
(GST), protein A (PrA)], utilized in immunoaffinity purification
experiments [either individually or in various combinations as
is done in a double-tag approach in tandem affinity purification
(TAP), or in a triple-tag approach in parallel affinity capture
(iPAC)], have all the potential to modify the degree of exposure
of individual MoRFs, drastically altering the in vivo fate
of the recombinant protein and the partners with which it
interact.
Biophysical and biochemical studies on wild-type human
CALR have been greatly facilitated by the availability of the
recombinant protein produced in large quantity in E. coli or
other expression systems. However, for reasons still unknown,
so far attempts to express the forms of CALR lacking the C-
domain found mutated in myeloproliferative disorders in E.
coli have been only partially successful and the mutant proteins
are available in minuscule amounts (Ann Mulally, personal
communication). This failure unveils the essential role played
by the C-domain on the survival of bacteria but also challenges
our ability to validate insights on the tertiary structure of the
mutated proteins obtained by in-silico analyses with experimental
approaches.
In conclusion, functional studies of chaperone proteins, such
as CALR, by recombinant technology are uniquely challenged
by their intrinsically disordered 3D-structure which may be
overcome by strict cooperation between and molecular biologists
with expert in protein chemistry and biophysics.
BIOLOGICAL FUNCTIONS OF CALR
CALR is involved in many cellular processes, both inside and
outside the ER (Wang et al., 2012). In the ER, CALR chaperones
nascent unfolded proteins and releases them to the site in
which they exert their biological activity and maintains Ca2+
homoeostasis. In fact, the C-domain of CALR binds more than
50% of Ca2+ present in the ER, thereby functioning as the main
Ca2+ storage (Nakamura et al., 2001; Michalak et al., 2009). In
addition, as a lectin-like molecular chaperone, CALR ensures
the proper conformation of newly synthesized glycoproteins,
interacting with calnexin and ERp57 in the calreticulin/calnexin
cycle, which guides misfolded proteins to the degradation
pathway (Michalak et al., 2009). The “folding checking unit” of
CALR is represented by its N- and P-domains (Nakamura et al.,
2001; Michalak et al., 2009).
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Whether CALR is an ER-restricted protein or is also localized
in other cellular compartments is an open question subjected to
active investigation. CALR may retro-translocate from the ER to
the cytosol, where the protein is involved in the regulation of cell
adhesion, thanks to a signal sequence present in the C-domain,
as well as plays a role in translation, gene expression, and nuclear
export (Afshar et al., 2005; Shaffer et al., 2005). In mice, CALR
exerts nuclear export function of the nuclear receptors, such as
the glucocorticoid receptor (GR) which involves migration to
the nucleus (Burns et al., 1994; Holaska et al., 2001). Although,
CALR regulates the nuclear export of GR also in human cells, in
human cells this activity does not require nuclear localization of
CALR but is exerted in regions of the ER located at the nuclear
border (Falchi et al., 2017), confirming previous studies which
had already indicated that nuclear localization of CALR may be
an artifact.
Several investigators have detected cell surface expression
of CALR by flow cytometry. On the cell surface, CALR
may antagonize the “eat-me” signal provided by CD47 to
macrophages. In fact, cell surface up-regulation of CALR has
been reported to antagonize phagocytosis of damaged cells
during the process of immunogenic cell death (Gardai et al.,
2005; Chao et al., 2010). In addition, on the plasma membrane,
CALR may function as a receptor for some orphan ligands, such
as thrombospondin (Goicoechea et al., 2002). The mechanism
responsible for exposing CALR on the cell surface is the subject
of active investigation. It is possible that this exposure occurs as
part of the continuous remodeling process to which the cellular
membranes are subjected.
Last but not least, although there is no report that CALR
may be secreted, it is detectable in the extracellular matrix where
it may be trapped as part of the degradation process of dead
cells. On the extracellular matrix, CALR, may stimulate wound
repair and healing by concentrating growth factors, such as
Transforming Growth Factor β3, responsible for the proliferation
and migration of keratinocytes and fibroblasts to the wound site
(Nanney et al., 2008).
CALR IN HUMAN STRESS
ERYTHROPOIESIS
CALR and GR are functionally linked by observations indicating
that both protein play important roles in the regulation of the
cellular response to a variety of stresses. GR is activated by
glucocorticoids secreted by the surrenal gland, which enter the
cells passively and binds the receptor in the cytoplasm inducing
its dimerization (Zhou and Cidlowski, 2005; Nicolaides et al.,
2010). GR dimers bind JAK2, inducing its phosphorylation, and
translocate to the nucleus, where they activate the expression
of a set of stress-responsive genes by binding to glucocorticoid
responsive elements (GRE) present in their regulatory regions
(Bauer et al., 1999; Zhou and Cidlowski, 2005). CALR exerts a
negative regulation on the cellular response to stress (Dedhar
et al., 1994). In fact, studies on murine fibroblasts transfected
with GFP-tagged proteins indicate that CALR induces nuclear
export of GR, thereby switching off the activation of the
stress-responsive genes, and making the cells susceptible to novel
ligand activation (Holaska et al., 2001). In these murine cells,
this function requires the N-CALR domain, which binds GR
(Roderick et al., 1997) and is induced by Ca2+ (Holaska et al.,
2002), suggesting that is regulated by the conformation of the C-
CALR domain (Villamil Giraldo et al., 2010; Wijeyesakere et al.,
2011).
In spite of the fact that the hematopoietic system is very
sensitive to stress, the functions of CALR in hematopoiesis are
still poorly defined. Some indications are starting to emerge on
the roles of this protein in the control of stress erythropoiesis,
a process of accelerated red cell production activated by anemia
induced by hemolysis, blood loss, or oxygen deprivation (Falchi
et al., 2017). This process is activated by a combination of
high levels of erythropoietin, glucocorticoids, soluble stem cell
factor, and bonemorphogenetic protein 4 (Erslev and Caro, 1986;
Tajima et al., 1998; von Lindern et al., 1999; Millot et al., 2010;
Wu and Paulson, 2010). The mechanisms which regulate stress
erythropoiesis in humans are studied mostly in in vitro models,
where hematopoietic progenitors are cultivated in the presence
of these growth factors (Varricchio and Migliaccio, 2014). These
culture conditions promote the proliferation of a unique class
of glucocorticoids-dependent erythroid progenitors (Migliaccio
et al., 2011; Xiang et al., 2015) which are capable to upregulate the
expression of specific stress responsive genes such as ZFP36L2
which confers them self-replication properties similar to those
of hematopoietic stem cells (Liu et al., 2013), thereby allowing
the generation of great numbers of red blood cells in a few days
(Migliaccio et al., 2002; Varricchio et al., 2011). These culture
systems were recently used by us to study the roles of CALR in the
stress response of human erythroid progenitor cells (Falchi et al.,
2017). This study revealed that in these cells, Ca2+ signaling,
possibly downstream to the erythropoietin receptor (Misiti and
Spivak, 1979), changes the conformation of C-CALR to the
state permissive for nuclear export of GR, resetting the stress-
responsiveness of the cells and allowing them to undergo the
terminal maturation process which had been inhibited by GR
activation.
ABNORMALITIES OF CALR IN CANCER
CALR Mutations Found in
Myeloproliferative Disorders
The most evident demonstration for a pathological role of CALR
in cancer etiology is provided by the observation that mutations
in exon 9 of CALR are found in the Philadelphia-negative
myeloproliferative neoplasms essential thrombocythemia and
primary myelofibrosis lacking JAK2V617F mutations (Klampfl
et al., 2013; Nangalia et al., 2013; Nunes et al., 2015). The
mutations may be represented either by base pair deletions
(Type 1) or insertions (Type 2) and generate a C-CALR domain
either shorter or longer than the wild-type one, but lacking
in either case the KDEL motif, suggesting that the mutated
proteins are not retained in the ER (Figure 1B). In addition
to KDEL, the mutations disrupt the low affinity Ca2+ binding
sites of the protein and three of the putative JAK2-dependent
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phosphorylation sites, suggesting that mutant proteins may bind
Ca2+ inefficiently and respond poorly to JAK2 activation. The C-
CALRmutants, especially those of type 2, which are characterized
by the presence of novel, highly basic C-tails, retain their
intrinsically disordered nature, but whether they have lost the
ability to affect the overall conformation of the protein, including
their effects on the conformation of the N-CALR and P-CALR
domains, has not been clarified as of yet.
Conformation of Mutant CALRs Found in
Myeloproliferative Disorders
Biophysical studies on protein structure and urea-induced
unfolding behavior of mutated CALR similar to those conducted
with the wild-type protein are not available as yet. Originally,
six different Type 1 and two different Type 2 indel mutations
had been identified (Klampfl et al., 2013; Nangalia et al., 2013;
Nunes et al., 2015). The list of CALR mutations found in
myeloproliferative disorders is however rapidly increasing, and
the most recent study described additional 16 Type 1 mutations
and three complex indel mutations (Nangalia et al., 2013;
Table 1).
While the important clinical question of possible correlations
between type of mutation and disease phenotype is currently
under investigation, attempts to correlate each mutation with its
theoretical effects on the disordered nature of CALR are scanty.
Still it is highly possible that mutation/phenotype correlations,
if they exist, have their basis on differences in protein functions
ultimately dictated by its structure. To fill this gap, we conducted
preliminary computational analysis, which revealed that the
overall disorder status of the C-terminal region of CALR was
moderately affected by the indel mutations. Figure 4 presents
the disorder profiles generated for wild type CALR and its indel
mutations by PONDR R© VLXT algorithm (Romero et al., 2001).
The changes found in the behavior disorder profiles were rather
expected since all the indel mutations possessed identical highly
disordered C-tails (last 36 residues), being different from each
other by the length of the remaining protein body (ranging from
360 to 385 residues) and the length of the disordered linker region
connecting CALR body with this newC-tail (ranging from 0 to 21
residues).
To begin understanding how indel mutations may affect the
interactivity of CALR, we also searched their sequence forMoRFs
with the ANCHOR algorithm (Dosztányi et al., 2009; Mészáros
et al., 2009). To this end, the AA sequence of each mutant
protein was analyzed by ANCHOR, and the respective outputs
were tabulated (see Table 1). Since indel mutations alter the AA
sequence of the C-terminal region of CALR, it was not surprising
that all the indel mutations are predicted to affect the two MoRFs
(MoRF4 and MoRF5) of the wild-type protein located in the C-
terminal half of C-CALR. However, in addition to these somehow
FIGURE 4 | Effects of the indel mutations found in myeloproliferative disorders on the intrinsic disorder predisposition of human CALR. Shown are disorder profiles
generated for wild-type CALR and its indel mutations by PONDR® VLXT algorithm (Romero et al., 2001). Since these mutations do not have any effect on the
N-CALR, P-domain, and the N-terminal half of C-CALR domain, the plot zooms in the C-terminal part of the C-CALR domain. We used the PONDR® VLXT program
because, although is not the most accurate disorder predictor, is sensitive to local peculiarities of the AA sequence and therefore is the program of choice to identify
disorder-based potential functional sites. The multiparametic analysis of intrinsic disorder predisposition of wild-type CALR is shown also shown in Figure 2 and is
published in Migliaccio and Uversky (2017). See Migliaccio and Uversky (2017).
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expected changes, five of the indel mutations introduce novel
MoRF4/5s whichmay bind novel partners. These findings predict
that mutant CALRs, in addition to be loss-of-function mutation
by lacking the KDEL motif and low affinity Ca2+ binding sites,
may be gain-of-function because they lost three putative JAK2-
dependent phosphorylation sites and acquired additional MoRFs
for novel partners. In spite of all the caveats described in the
previous section, studies on the interactome of the various
mutant CALRs are badly necessary to validate this hypothesis.
Alterations of the Biological Activity of
CALR in Myeloproliferative Disorders
Surprisingly, the phenotype of myeloproliferative disorders
associated with CALR mutations includes growth factor
independent activation of JAK2 (Klampfl et al., 2013; Nangalia
et al., 2013), and these patients respond to treatment with JAK
inhibitors, such as Ruxolitinib (Cervantes et al., 2013; Passamonti
et al., 2014). Studies in human megakaryocytic-erythroleukemic
cell lines and in mouse models have elucidated that CALR binds
to the cytokine receptor homology domain of all the receptors
of the hematopoietic superfamily, including the thrombopoietin
(MPL), the erythropoietin, and the G-CSF receptor, and that
binding of the mutated, but not wild-type, CALR to MPL, but
not to the receptor of EPO or G-CSF, acts as a ligand-mimetic
activating JAK2 (Araki et al., 2016; Chachoua et al., 2016).
These results have established a common pathological pathway
for myeloproliferative disorders caused by JAK2 or CALR
mutations.
Conversely, the putative JAK2-dependent phosphorylation
sites present in wild-type CALR suggest that in
myeloproliferative disorders JAK2 mutations may affect the
function of this protein. The observation that in normal
erythroid progenitors, Ca2+ signaling, possibly downstream
to EPO receptor, activates the nuclear GR export functions of
CALR inspired us to use this function as a bait to assess whether
JAK2V617F alters the functions of wild-type C-CALR. This
study investigated the nuclear export activity of wild-type CALR
in erythroid progenitors from patients with Polycythemia Vera
carrying the JAK2V617F mutation (Falchi et al., 2017). The
results indicated that in contrast with normal cells, in erythroid
progenitors from JAK2+ Polycythemia Vera, C-CALR is not
associated and does not induce nuclear export of GR, which
remain constitutively active in the nucleus, possibly contributing
to their hyper-proliferation (Figure 5A). Therefore, JAK2V617F
impairs at least the nuclear export activity of CALR. Further
studies are necessary to elucidate the full spectrum of CALR
functions impaired by JAK2V617F, the variegation of these
alterations in disorders with different phenotypes and how these
alterations are related to those induced by CALRmutations.
A peek at possible differences between abnormalities in CALR
functions induced by JAK2V617F mutations in diseases with
different phenotypes is provided by the confocal microscopy
observations presented in Figure 5A. These data indicate that
the CALR/GR association is impaired and nuclear retention
of GR is abnormally high in JAK2V617F patients expressing
both the Polycythemia Vera and the Primary Myelofibrosis
phenotype. By contrast with Polycythemia Vera patients who
experience erythrocytosis, patients with Primary Myelofibrosis
express anemia which is not always responsice to erythroid-
stimulating agents. The observation that erythroid progenitor
cells from Primary Myelofibrosis retain some level of CALR/GR
association displaying more GR in the cytoplasm than those
from Polycythemia Vera suggests that these cells may be at
least partially responsive to glucocorticoids and may explain
anectodical reports that indicate that a fraction (3 out of
10) of Primary Myelofibrosis patients resistant to classic
erythroid-stimulating agents (Hernández-Boluda et al., 2017)
are cured of their underlying anemia and became transfusion-
independent when treated with glucocorticods (G. Barosi,
personal communication, May 2017). The reason why only some
of the Primary Myelofibrosis patients respond to glucocorticoids
is still to be determined. The inhibitory effect exerted by
JAK2V617F on nuclear export of GR described above suggests
that patients with high JAK2V617F allele burden are those
that became glucocorticoids non responsive. Further studies are
necessary to test this hypothesis.
Support for the hypothesis that the JAK2 mutation may affect
CALR functions is further provided by the flow cytometry study
presented in Figure 5B. By flow cytometry, CALR is readily
detected on the cell-surface of normal erythroid progenitors
and remain expressed in cells undergoing terminal maturation
up to the polycromatophilic stage (Figure 5B). In these normal
cells, cell-surface expression of CALR is not affected by Ca2+.
Erythroid cells from JAK2V617F myeloproliferative disorders
express cell-surface levels of CALR similar to those expressed
by normal cells. This observation is consistent with the
recent report indicating that CALR is expressed within normal
ranges by a variety of hematopoietic cells from patients with
the myeloproliferative neoplasm Essential Thrombocythemia
(Daitoku et al., 2016). By contrast with normal cells, however,
Ca2+ upregulates the levels of CALR expressed on the surface
of erythroid cells from JAK2+ patients but not, as expected,
in those from patients harboring CALR mutations with an
impaired C-CALR domain which are unable to bind Ca2+
(Figure 5B), suggesting that under certain conditions anti-
CD47/CALR therapies (see later) are likely to be effective in
myeloproliferative neoplasms. In addition, several groups are
currently investigating whether, by altering the intrinsically
disordered nature of the protein, these driver mutations induce
the appearance of novel, possibly immunogenic, CALR epitopes
to be used to generate immune-specific therapies.
Alterations of the Biological Activity of
CALR in Other Hematological and Solid
Tumors
CALR is involved in the etiology not only of myeloproliferative
disorders but also in that of many other cancers (Zamanian
et al., 2013). By contrast with myeloproliferative neoplasms,
driver mutations in CALR have not been associated with
other hematological or solid tumors as yet. However, at least
114 single nucleotide polymorphism sites (SNPs) distributed
along the exons have been described as somatic mutations
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FIGURE 5 | The JAK2V617F mutation abrogates the association between CALR and the glucocorticoid receptors in patients with Polycythemia Vera. It also makes
the mutant erythroid progenitors capable to up-regulate the cell surface expression of CALR in response to Ca2+. (A) Single and merged confocal microscopy
observations of a representative erythroid progenitor cell expanded in culture from patients with JAK2+ Polycythemia Vera (PV) and Primary Myelofibrosis (PMF)
stained with antibodies against C-CALR (red) or the glucocorticoid receptor (green), as indicated. Merged areas are in yellow. Nuclei were counterstained in blue with
DAPI. Original magnification: 1,200x. The bar corresponds to 10µm. The results with PV are similar to those published in (Falchi et al., 2017). The results with PMF are
not published and were obtained in experiments conducted in parallel with those on PV. Technical details are provided in and are also shown in Figure 2. *Indicates
values statistically different (p < 0.05) between PV and PMF. (B) Levels of N-CALR detected by flow cytometry on the cell surface of erythroid cells expanded in vitro
from non-diseased donors (ND, 2 different subjects) or from patients with myeloproliferative neoplasms carrying either the JAK2V617F or the Type 2 CALR+ mutation
(2 patients in each group) and treated in vitro for 2 h with EPO in the presence of either Ca2+-depleted or Ca2+-supplemented phosphate buffered saline. Results are
expressed as Mean Fluorescence intensity (MFI) obtained in separate experiments performed in duplicate. Erythroid cells were divided into classes of progressive
maturation (proerythroblasts, basophilic, polychromatophilic, and orthochromatic erythroblasts) according to established flow cytometry criteria based on CD36 and
CD235a staining (Migliaccio et al., 2011). The levels of cell surface expression of N-CALR between cells exposed or not to Ca2+ is statistically different (by Anova) only
for erythroid cells harboring the JAK2 mutation. The results of the cells not treated with Ca2+ were already published in Falchi et al. (2017). The technical details of
these experiments are provided in Falchi et al. (2017).
of the CALR gene (located on human 19p13.13) in a variety
of cancers (see https://hive.biochemistry.gwu.edu/biomuta,
UniProt_AC P27797, Accession Number: NM_004343). The
curated SNPs and disease association database reports that
somatic CALR SNP variants are present in patients with at
least 20 different types of hematologic malignancies and solid
cancers, suggesting that they increase the susceptibility of
normal cells to develop driver mutations (Lundberg et al.,
2014; Malcovati et al., 2014). Among these 114 mutations,
66 are non-synonymous variations, 40 of which are unique
substitutions which have either benign (22 SNPs) or possibly
damaging (16 SNPs) consequences on disease phenotype
(Table 2). These SNPs are distributed along all of the functional
domains of CALR: one SNP is found in the signal peptide, 14
in N-CALR, 6 in P-CALR, and 19 in C-CALR, respectively.
Most SNPs have as predicted biochemical consequence gain
of phosphorylation sites but gain of glycosylation and loss of
binding sites have also been described. The little information on
the biological relevance of post-translational modification
of CALR currently available limits our understanding
of the contribution played by alterations of the post-
translational modification sites of CALR in the etiology of
cancer.
The vast majority of these SNPs are located either in
disordered or flexible regions (i.e., regions characterized
by the predicted disorder scores PDS ≥ 0.5 or 0.2 ≤
PDS < 0.5, respectively). This is an interesting observation
that further supports the hypothesis that these intrinsically
disordered/flexible regions play an important role in the
functionality of human CALR. To start delineate the effects
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TABLE 2 | Effects of different somatic SNPs most commonly found in cancer on the intrinsic disorder-based interactivity of human CALR.
SNPs AA Substitutions Predicted function MoRF1 MoRF2 MoRF3 MoRF4 MoRF5
wt N/A Wild type CALR 170–176 198–204 259–269 304–352 409–417
13 V5M – 170–176 198–204 259–269 304–352 409–417
79 F27L – 170–176 198–204 259–269 304–352 409–417
133 D45Y – 170–176 198–204 259–269 304–352 409–417
137 F46Y Gain/Phosphorylation 170–176 198–204 259–269 304–352 409–417
151 L51V – 170–176 198–204 259–269 304–352 409–417
168 F56L Gain/Phosphorylation 170–176 198–204 259–269 304–352 409–417
186 K62N Gain/Phosphorylation 170–176 198–204 259–269 304–352 409–417
185 K62R Gain/Phosphorylation 170–176 198–204 259–269 304–352 409–417
191 K64T Loss/Acetylation 170–176 198–204 259–269 304–352 409–417
201 Q67H – 170–176 198–204 259–269 304–352 409–417
298 E100Q Gain/Phosphorylation 170–176 198–204 259–269 304–352 409–417
365 M122T Gain/Phosphorylation 170–176 198–204 259–269 304–352 409–417
383 Y128C Loss/Binding Site 170–176 198–204 259–269 304–352 409–417
394 F132L Gain/Phosphorylation 170–176 198–204 259–269 304–352 409–417
562 N188D – 170–176 198–204 259–269 304–352 409–417
610 P204S – 170–176 198–205 259–269 304–352 409–417
700 E234K Gain/Phosphorylation 170–176 199–205 263–269 304–352 409–417
720 E240D Gain/Phosphorylation 170–176 198–204 259–269 304–352 409–417
731 D244G – 170–176 198–204 259–269 304–352 409–417
892 E298Y – 170–176 198–204 257–296
899 S300Y – 170–176 198–204 263–268 303–350 409–417
925 D309Y Gain/Phosphorylation 170–176 198–204 304–350 409–417
968 S323F – 170–176 198–204 259–268 304–350 409–417
1003 D335N – 170–176 198–204 259–269 304–352 409–417
1022 E341G Gain/Glycosylation 170–176 198–204 259–269 304–352 409–417
1028 G343D – 170–176 198–204 259–269 304–352 408–417
1103 K368M – 170–176 198–204 259–269 304–352 408–417
1113 E371D – 170–176 198–204 259–269 304–352 408–417
1121 K374R – 170–176 198–204 259–269 304–352 409–417
1137 E379D – 170–176 198–204 259–269 304–352 408–417
1142 E381G – 170–176 198–204 259–269 304–352 409–417
1157 E386G – 170–176 198–204 259–269 304–352 409–417
1167 E389D – 170–176 198–204 259–269 304–352 408–417
1192 E398K – 170–176 198–204 259–269 304–352 409–417
1207 E403Y – 170–176 198–204 259–269 304–350
1212 D404E – 170–176 198–204 259–269 304–352 409–417
1213 E405Q – 170–176 198–204 259–269 304–352 408–417
1229 P410L – 170–176 198–204 259–269 304–351 406–417
1240 K414E – 170–176 198–204 259–269 304–352 408–417
1245 D415E – 170–176 198–204 259–269 304–352 409–417
Information on SNP identification number (column 1) and description of the related AA substitution (columns 2), as well as predicted functional outputs (column 3) were taken from
https://hive.biochemistry.gwu.edu/biomuta. Expected effects of SNPs on the interactivity of CALR were evaluated by the ANCHOR algorithm (Dosztányi et al., 2009; Mészáros et al.,
2009). To this end, the AA sequence of each mutant identified in column 2 was analyzed by ANCHOR and the corresponding outputs (positions of MoRFs) were tabulated. SNPs with
possibly/probably damaging effects on disease phenotype are indicated in red. MoRFs alterations caused by SNPs are highlighted in yellow.
of these SNPs on the tertiary structure of CALR, we used a
set of commonly used disorder predictors such as PONDR R©
FIT (Xue et al., 2010), PONDR R© VSL2 (Obradovic et al.,
2005), and PONDR R© VL3 (Peng et al., 2005) to predict the
effects of some of these SNPs on the disorder profiles of the
human protein (Figure 6A). The effects on the intrinsic disorder
predisposition of specific domains was instead determined by
the PONDR R© VSL2 predictor (Obradovic et al., 2005) in
a form of “disorder difference spectra” that were calculated
as a simple difference between the PONDR R© VSL2 disorder
curves calculated for variant and wild-type forms of CALR
(Figures 6B–D). Obviously, in this presentation, negative or
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FIGURE 6 | Effects of somatic single-nucleotide polymorphisms (SNPs) of CALR detected in cancer patients on the intrinsic disorder nature of the protein. (A) Intrinsic
disorder propensity of human CALR evaluated by PONDR® VSL2 (red), PONDR® VL3 (dark red), and PONDR® FIT (pink). PONDR® VSL2 is a rather accurate
stand-alone disorder predictor suitable for proteins containing ordered and intrinsically disordered regions. PONDR® VL3 is developed for accurate prediction of long
disordered regions. Metapredictor PONDR® FIT is one of the more accurate disorder predictors. Position of 40 unique non-synonymous mutations are shown by cyan
bars. Light pink shadow around the PONDR® FIT shows error distribution. In these analyses, predicted intrinsic disorder scores above 0.5 are considered to
correspond to the disordered residues/regions, whereas regions with the disorder scores between 0.2 and 0.5 are considered flexible. (B–D) “Difference disorder
spectra” calculated as a difference between the per-residue disorder propensity evaluated by the PONDR® VSL2 for the mutant forms of human CALR and the
per-residue disorder propensity evaluated by the PONDR® VSL2 for the wild-type protein. The protein sequence is split into three parts to zoom into the N-CALR (B),
the P-CALR (C), and the C-CALR (D) domain. The multiparametic analysis of intrinsic disorder predisposition of wild-type human CALR was published in Migliaccio
and Uversky (2017; see also Figure 2). See Migliaccio and Uversky (2017).
positive peaks correspond to SNPs leading to local decrease or
increase in the intrinsic disorder propensity, respectively. Since
CALR contains numerous SNPs, to show effects of each variant
in more detail, results corresponding to the N-CALR, P-domain,
and C-CALR domains are presented in different panels. Figure 6
shows thatmany SNPs have profound effects on the local disorder
propensity of this protein. The largest distortion in the local
disorder predisposition was found for variants located within
the more ordered N-CALR domain. In fact, all mutations in
this region caused at least some changes in the local disorder
propensity. Also, mutations within the more ordered C-terminal
part of the P-domain (E298X and S300Y) and N-terminal
part of C-CALR (D309Y, S323F, E341G, D335N, and G343D)
caused noticeable alterations in the local disorder predisposition,
whereas local disorder propensities of the highly disordered parts
of the P-domain and C-tail of C-CALR were either not altered
at all (mutations P204S, E234K, and E240D in P-domain and
E379D, E381G, E386G, E389G, E398K, K403X, D404E, E405Q,
P410L, K414E, and D415E in C-CALR) or experienced rather
minor distortions (e.g., mutations K368M, E371D, and K374R;
see Figures 6B–D).
We also analyzed how pathological point mutations might
affect disorder-based potential binding sites of CALR by
subjecting sequences of its mutants to ANCHOR analysis
(Dosztányi et al., 2009; Mészáros et al., 2009). The analysis
is summarized in Table 2 and indicates that MoRF1 was not
affected by any variants. However, MoRF2 was extended by
1 residue by P204S, MoRF3 was reduced by 4 residues by
E234K (264–269). In addition, E298X introduced a premature
stop codon and removed the C-tail with MoRF4 and MoRF5,
S300Y affected MoRF3 (263–268) and MoRF4 (303–350), D309Y
eliminated MoRF3 and changed MoRF4 (304–350), S323F
mutation changed MoRF4 (304–350); G343D, K368M, E371D,
E379D, E389D, E405Q, and K414E each extended MoRF5 by 1
residue (408–417), K403X introduced a premature stop codon,
removed the C-tail with MoRF5 and shrunk MoRF4 by two
residues (304–350), P410L decreased MoRF4 by one residue
(304–351) and extended MoRF5 by three residues (406–417).
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Overall, these analyses showed that most of the clinically relevant
SNPs affect MoRF3 and/or MoRF5. Therefore, it is conceivable
that at least some of these changes alter the interactome of
CALR. These predictions based on computer-modeling must
be confirmed by additional biophysical and biochemical studies
similar to those discussed earlier for the wild-protein.
In general, the biological consequences of somatic CALR SNPs
associated with cancer are far less characterized than those of
the mutant proteins found in myeloproliferative neoplasms. The
major CALR defect described so far in cancer cells regards the
levels of cell-surface expression. CALR is expressed at abnormally
high levels on the cell-surface of a wide variety of cancer
cells, including some hematological malignancies (Wemeau
et al., 2010; Zamanian et al., 2013, 2016), suggesting that, by
antagonizing the “eat-me” signal provided by CD47, CALR may
promote disease progression via inhibition of the surveillance by
the immune system (Obeid et al., 2007; Chao et al., 2010). These
observations are guiding the development of drugs that target
the CD47/CALR pathway as a way to treat cancer by reactivating
the immune surveillance system (Chao et al., 2011; Majeti, 2011;
Kong et al., 2016). This is such a potentially important area of
research that deserves to be further investigated.
CONCLUSIONS
CALR is emerging as a structural “chameleon” protein with
multiple structural facets, each one involved in specific functions.
Mutations affecting the integrity of its Ca2+-binding domain
alters the proliferation of hematopoietic cells at levels that induce
myeloproliferative neoplasms. In addition, somatic mutations
distributed along all the sequence of the gene with the potential to
determine fine differences in protein activity are found in many
cancers. These CALR variants may represent genetic modifiers
that facilitate the development of driver mutations and/or alter
the natural history of the disease. Hence, the great clinical
interest to develop novel prognostic/therapeutic tools by gaining
a deeper understanding on the biological function of CALR.
The intrinsic disordered nature of this protein, however, is such
that it may be a mistake to consider CALR as just one protein.
This hypothesis and theory article has discussed how each one
of its alternative conformational ensembles may exert specific
functions and challenge future studies on the association of a
specific ensemble with a specific function in the next few years.
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